|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Total revenues | |||||
| Operating expenses: | |||||
| Cost of sales | |||||
| Research and development | |||||
| Selling, general, and administrative | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Impairment of investment in privately-held company | |||||
| Total other income, net | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Net income per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
